Iværksætterlæge får 13 mio af EU til klinisk studie

Med en frisk millionbevilling fra EU's Horizon 2020-program kan det danske selskab Neurescue næste år sætte gang i kliniske studier med dets hjerteudstyr.

Neurescue-teamet, fra venstre til højre: Klinisk direktør Anette Kristiansen, formand Peter Sebelius, adm. direktør Habib Frost og direktør for forretningsudvikling Bjørn Broby Glavind. | Photo: Neurescue PR

by ELIZABETH MØNSTED JOHANSEN

Opstartsvirksomheden Neurescue har sikret sig 13 mio. kr. fra EU’s Horizon 2020 SME-program, der skal støtte forsknings- og udviklingsprojekter hos mindre, nye selskaber.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

Access all locked articles
Receive our daily newsletters
Access our app

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Front page now

The Jera Capital Trio, Alexander Reventlow, Christen Estrup and Julien Marencic, left their desks at Nordea AM in the fall of 2021 to follow their dream of going independent. Photo/PR | Foto: Pr / Jera Capital

Fund Management

Secondary private equity trio “very bullish” in a market lacking capital

For newly established secondary private equity specialists at Jera Capital, the biggest challenge is to stay disciplined in a market full of discounts. Humbled by challenging market conditions, the former Nordea AM trio sees their fundraising aspirations so far unfulfilled.

For subscribers